| Haidar, Ahmad |
SEMA SMA, NCT06387199: Alleviating Carbohydrate Counting for Patients With Type-1 Diabetes Using a Closed Loop System With Weekly Subcutaneous Semaglutide |
|
|
| Not yet recruiting | 2/3 | 26 | Canada | Semaglutide with 4 meal strategies, Placebo with 4 meal strategies | McGill University Health Centre/Research Institute of the McGill University Health Centre | Type 1 Diabetes, Diabetes Mellitus | 07/26 | 07/26 | | |
SEMA-AP, NCT05205928: Weekly Subcutaneous Semaglutide as Adjunct to Closed-loop Therapy in Type 1 Diabetes Care |
|
|
| Active, not recruiting | 2/3 | 28 | Canada | Outpatient therapy: 11 weeks of drug therapy with usual treatment + 4 weeks of closed-loop therapy | McGill University Health Centre/Research Institute of the McGill University Health Centre | Type 1 Diabetes, Diabetes Mellitus, Type 1 | 04/24 | 06/24 | | |
FCL, NCT06046417: A Fully Automated Lyumjev and Pramlintide Delivery System for Adults With Type 1 Diabetes |
|
|
| Recruiting | 2/3 | 30 | Canada | Pramlintide, Lyumjev, Automated Insulin Delivery (AID) system | McGill University Health Centre/Research Institute of the McGill University Health Centre, Juvenile Diabetes Research Foundation | type1diabetes, Diabetes Mellitus, Type 1 | 04/25 | 06/25 | | |
Lilly-MEALS, NCT06021158: A Trial to Compare Automated Lyumjev Delivery With Carbohydrate Counting, Qualitative Meal-size Estimation, and Meal Detection in Type 1 Diabetes |
|
|
| Recruiting | 2 | 12 | Canada | Hybrid automated Lyumjev delivery system with carbohydrate counting, Hybrid automated Lyumjev delivery system with meal size estimation, Fully automated Lyumjev delivery system with meal detection | McGill University Health Centre/Research Institute of the McGill University Health Centre | Diabetes Mellitus, Type 1, Type 1 Diabetes | 12/24 | 12/24 | | |
NCT04612257: Assessing Closed-loop Insulin Delivery in Children With Type 1 Diabetes. |
|
|
| Terminated | N/A | 10 | Canada | Insulin-alone closed-loop | McGill University, Eli Lilly and Company | Diabetes Mellitus, Type 1 | 06/22 | 06/22 | | |
NCT05041621: A Learning Algorithm for MDI Individuals With Type 1 Diabetes to Adjust Recommendations for High Fat Meals and Exercise Management |
|
|
| Completed | N/A | 15 | Canada | Sensor augmented MDI therapy plus mobile application | McGill University | Type 1 Diabetes | 02/23 | 02/23 | | |
FCL, NCT05199714: A Fully-closed Loop, Pramlintide and Insulin, Artificial Pancreas Clinical Trial for Adults With Type 1 Diabetes |
|
|
| Completed | N/A | 12 | Canada | Fiasp, Artificial Pancreas, Pramlintide, Aspart | McGill University Health Centre/Research Institute of the McGill University Health Centre, Juvenile Diabetes Research Foundation | Type 1 Diabetes | 03/23 | 03/23 | | |
NCT04123054: A Novel mHealth Application Guided by an Optimization Algorithm for T1D Sensor-Augmented Insulin Injection Users |
|
|
| Completed | N/A | 84 | Canada | Mobile App, Mobile App + Basal-Bolus Optimization Algorithm | McGill University | Diabetes Mellitus, Diabetes Mellitus, Type 1 | 12/23 | 01/24 | | |
NCT04243629: Co-administration of Pramlintide and Insulin Via an Automated Dual-hormone Artificial Pancreas System in Adults With Type 1 Diabetes |
|
|
| Recruiting | N/A | 26 | Canada | Rapid-Acting Insulin, Placebo, Pramlintide Acetate, Artificial Pancreas | McGill University, Canadian Institutes of Health Research (CIHR) | Diabetes Mellitus, Type 1, Type 1 Diabetes, Postprandial Hyperglycemia | 04/24 | 04/24 | | |
